Citation: | JIA Zhimeng, Rebecca Colman, NING Xiaohong. Interpretation on Management of Dyspnea in Advanced Cancer: ASCO Guideline[J]. Medical Journal of Peking Union Medical College Hospital, 2024, 15(1): 52-57. DOI: 10.12290/xhyxzz.2023-0517 |
[1] |
Solano J P, Gomes B, Higginson I J. A comparison of symptom prevalence in far advanced cancer, AIDS, heart disease, chronic obstructive pulmonary disease and renal disease[J]. J Pain Symptom Manage, 2006, 31(1): 58-69. DOI: 10.1016/j.jpainsymman.2005.06.007
|
[2] |
Sullivan D R, Iyer A S, Enguidanos S, et al. Palliative care early in the care continuum among patients with serious respiratory illness: an official ATS/AAHPM/HPNA/SWHPN policy statement[J]. Am J Respir Crit Care Med, 2022, 206(6): e44-e69. DOI: 10.1164/rccm.202207-1262ST
|
[3] |
Dy S M, Gupta A, Waldfogel J M, et al. Interventions for breathlessness in patients with advanced cancer: comparative effectiveness review, No. 232[R]. Rockville, MD: Agency for Healthcare Research and Quality, 2020.
|
[4] |
Gupta A, Sedhom R, Sharma R, et al. Nonpharmacological interventions for managing breathlessness in patients with advanced cancer: a systematic review[J]. JAMA Oncol, 2021, 7(2): 290-298. DOI: 10.1001/jamaoncol.2020.5184
|
[5] |
Aucoin R, Lewthwaite H, Ekström M, et al. Impact of trigeminal and/or olfactory nerve stimulation on measures of inspiratory neural drive: Implications for breathlessness[J]. Respir Physiol Neurobiol, 2023, 311: 104035. DOI: 10.1016/j.resp.2023.104035
|
[6] |
Kako J, Morita T, Yamaguchi T, et al. Fan therapy is effective in relieving dyspnea in patients with terminally ill cancer: a parallel-arm, randomized controlled trial[J]. J Pain Symptom Manage, 2018, 56(4): 493-500. DOI: 10.1016/j.jpainsymman.2018.07.001
|
[7] |
Ting F I, Estreller S, Strebel H M J. The FAFA trial: a phase 2 randomized clinical trial on the effect of a fan blowing air on the face to relieve dyspnea in Filipino patients with terminal cancer[J]. Asian J Oncol, 2020, 6(1): 3-9. DOI: 10.1055/s-0040-1708112
|
[8] |
Wong S L, Leong S M, Chan C M, et al. The effect of using an electric fan on dyspnea in Chinese patients with terminal cancer[J]. Am J Hosp Palliat Care, 2017, 34(1): 42-46. DOI: 10.1177/1049909115615127
|
[9] |
Quill T E, Holloway R. Time-limited trials near the end of life[J]. JAMA, 2011, 306(13): 1483-1484. DOI: 10.1001/jama.2011.1413
|
[10] |
Loewenstein G. Hot-cold empathy gaps and medical decision making[J]. Health Psychol, 2005, 24(4S): S49-S56.
|
[11] |
Doǧan N, Taşci S. The effects of acupressure on quality of life and dyspnea in lung cancer: a randomized, controlled trial[J]. Altern Ther Health Med, 2020, 26(1): 49-56.
|
[12] |
Wyatt G, Sikorskii A, Rahbar M H, et al. Health-related quality-of-life outcomes: a reflexology trial with patients with advanced-stage breast cancer[J]. Oncol Nurs Forum, 2012, 39(6): 568-577. DOI: 10.1188/12.ONF.568-577
|
[13] |
McCarthy B, Casey D, Devane D, et al. Pulmonary rehabilitation for chronic obstructive pulmonary disease[J]. Cochrane Database Syst Rev, 2015, 2015(2): CD003793.
|
[14] |
Hui D, Kilgore K, Frisbee-Hume S, et al. Effect of prophylactic fentanyl buccal tablet on episodic exertional dyspnea: a pilot double-blind randomized controlled trial[J]. J Pain Symptom Manage, 2017, 54(6): 798-805. DOI: 10.1016/j.jpainsymman.2017.08.001
|
[15] |
Cuervo Pinna M Á, Bruera E, Redondo Moralo M J, et al. A randomized crossover clinical trial to evaluate the efficacy of oral transmucosal fentanyl citrate in the treatment of dyspnea on exertion in patients with advanced cancer[J]. Am J Hosp Palliat Care, 2015, 32(3): 298-304. DOI: 10.1177/1049909113513063
|
[16] |
Charles M A, Reymond L, Israel F. Relief of incident dyspnea in palliative cancer patients: a pilot, randomized, controlled trial comparing nebulized hydromorphone, systemic hydromorphone, and nebulized saline[J]. J Pain Symptom Manage, 2008, 36(1): 29-38. DOI: 10.1016/j.jpainsymman.2007.08.016
|
[17] |
Benyamin R, Trescot A M, Datta S, et al. Opioid complications and side effects[J]. Pain Physician, 2008, 11(2 Suppl): S105-S120.
|
[18] |
Reddy S K, Parsons H A, Elsayem A, et al. Characteristics and correlates of dyspnea in patients with advanced cancer[J]. J Palliat Med, 2009, 12(1): 29-36. DOI: 10.1089/jpm.2008.0158
|
[19] |
Hui D, Puac V, Shelal Z, et al. Effect of dexamethasone on dyspnoea in patients with cancer (ABCD): a parallel-group, double-blind, randomised, controlled trial[J]. Lancet Oncol, 2022, 23(10): 1321-1331.
|
[20] |
Nici L, Mammen M J, Charbek E, et al. Pharmacologic management of chronic obstructive pulmonary disease. An official American Thoracic Society clinical practice guideline[J]. Am J Respir Crit Care Med, 2020, 201(9): e56-e69. DOI: 10.1164/rccm.202003-0625ST
|